Predictive power of quantitative and qualitative fecal immunochemical tests for hemoglobin in population screening for colorectal neoplasm

European Journal of Cancer Prevention

Volumn 23, Issue 1, 2014, Pages 27-34

  Huang, Yanqin ^a   Li, Qilong ^b   Ge, Weiting ^a   Cai, Shanrong ^a   Zhang, Suzhan ^a   Zheng, Shu ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Jiashan Institute of Oncology Prevention and Treatment   (China)

Author keywords

Colorectal cancer screening; Comparative study; Detection rate; Fecal immunochemical test; Mass screening; Positive predictive rate

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANALYZER; ARTICLE; AUTOMATION; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL POLYP; COLORECTAL TUMOR; CONTROLLED STUDY; DEFECATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; FECAL BLOOD ANALYZER; FECAL IMMUNOCHEMICAL TEST; FECES; FECES ANALYSIS; FEMALE; FIT DIPSTICK; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOCHEMISTRY; IMMUNOGOLD LABELING; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

ADULT; AGED; CHINA; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 84889249401     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328364f229     Document Type: Article

References (31)

1. Allison JE, Tekawa IS, Ransom LJ, Adrain AL (1996). A comparison of fecal occult-blood tests for colorectal-cancer screening. N Engl J Med 334: 155-159. (Pubitemid 26017953)
2. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, et al. (2007). Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 99:1462-1470.
3. Burt RW, Barthel JS, Dunn KB, David DS, Drelichman E, Ford JM, et al. (2010). NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw 8:8-61.
4. Dancourt V, Lejeune C, Lepage C, Gailliard MC, Meny B, Faivre J (2008). Immunochemical faecal occult blood tests are superior to guaiac-based tests for the detection of colorectal neoplasms. Eur J Cancer 44: 2254-2258.
5. Guittet L, Guillaume E, Levillain R, Beley P, Tichet J, Lantieri O, et al. (2011). Analytical comparison of three quantitative immunochemical fecal occult blood tests for colorectal cancer screening. Cancer Epidemiol Biomarkers Prev 20:1492-1501.
6. Halloran SP, Launoy G, Zappa M (2012). European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition - faecal occult blood testing. Endoscopy 44 (Suppl 3):SE65-SE87.
7. Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, et al. (2009). Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 100:1103-1110.
8. Hol L, de Jonge V, van Leerdam ME, van Ballegooijen M, Looman CW, van Vuuren AJ, et al. (2010a). Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy. Eur J Cancer 46:2059-2066.
9. Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, et al. (2010b). Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 59:62-68.
10. Hundt S, Haug U, Brenner H (2009). Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med 150:162-169.
11. Launoy GD, Bertrand HJ, Berchi C, Talbourdet VY, Guizard AV, Bouvier VM, et al. (2005). Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general averagerisk population. Int J Cancer 115:493-496. (Pubitemid 40663756)
12. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, et al. (2007). A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 146:244-255. (Pubitemid 351650610)
13. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS, et al. (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 58:130-160. (Pubitemid 351830299)
14. Li S, Wang H, Hu J, Li N, Liu Y, Wu Z, et al. (2006). New immunochemical fecal occult blood test with two consecutive stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients. Int J Cancer 118:3078-3083.
15. Lieberman DA, Weiss DG (2001). One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 345:555-560. (Pubitemid 32772096)
16. Lisa C, Richardson ET, Rim SH, Joseph D, Plescia M (2011). Vital signs: colorectal cancer screening, incidence, and mortality - United States, 2002-2010. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm60 26a4.htm?s-cid=mm6026a4-w [Accessed 15 October 2012].
17. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y (2005). A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 129: 422-428. (Pubitemid 41096630)
18. Noboru G, Michiko F, Keiko I, Miki T, Sanae O, Junko M, Yoshimaro K (2002). Basic study of OC-SENSOR μ, a compact fully automated immunochemistry analyzer for fecal occult blood tests. J Clin Lab Instrum Reag 25: 57-62.
19. Park DI, Ryu S, Kim YH, Lee SH, Lee CK, Eun CS, et al. (2010). Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening. Am J Gastroenterol 105:2017-2025.
20. Parra-Blanco A, Gimeno-Garcia AZ, Quintero E, Nicolas D, Moreno SG, Jimenez A, et al. (2010). Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening. J Gastroenterol 45: 703-712.
21. Ping Zhao WC (2011). Chinese Cancer Registry Annual Report - cancer incidence and mortality in Chinese cancer registration areas in 2007. Beijing: Military Medical Science Press.
22. Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas A, et al. (2012). Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 366:697-706.
23. Rosman AS, Korsten MA (2010). Effect of verification bias on the sensitivity of fecal occult blood testing: a meta-analysis. J Gen Intern Med 25:1211-1221.
24. Smith A, Young GP, Cole SR, Bampton P (2006). Comparison of a brushsampling fecal immunochemical test for hemoglobin with a sensitive guaiacbased fecal occult blood test in detection of colorectal neoplasia. Cancer 107:2152-2159. (Pubitemid 44665648)
25. Smith RA, Cokkinides V, Brawley OW (2012). Cancer screening in the United States, 2012: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 62:129-142.
26. Soon MS, Kozarek RA, Ayub K, Soon A, Lin TY, Lin OS (2005). Screening colonoscopy in Chinese and Western patients: a comparative study. Am J Gastroenterol 100:2749-2755.
27. Telford JJ (2011). Canadian guidelines for colorectal cancer screening. Can J Gastroenterol 25:479-481.
28. Van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, Jansen JB, et al. (2009). Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer 101:1274-1281.
29. Walsh JM, Terdiman JP (2003). Colorectal cancer screening: scientific review. JAMA 289:1288-1296. (Pubitemid 37432910)
30. Wong BC, Wong WM, Cheung KL, Tong TS, Rozen P, Young GP, et al. (2003). A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population. Aliment Pharmacol Ther 18:941-946. (Pubitemid 37346679)
31. Wong CK, Fedorak RN, Prosser CI, Stewart ME, van Zanten SV, Sadowski DC (2012). The sensitivity and specificity of guaiac and immunochemical fecal occult blood tests for the detection of advanced colonic adenomas and cancer. Int J Colorectal Dis 27:1657-1664.